Researchers have demonstrated the role of CDKN2B‐AS in cervical cancer through in vivo experiments, including tumor growth, apoptosis inhibition, and senescence inhibition, and CDKN2B‐AS1 knockdown can inhibit the above activities.29 The gene discussed is CDKN2B; the disease is cervical cancer.